Saiber Attorney Profile: Jakob B. Halpern

Jakob B. Halpern

Associate

18 Columbia Turnpike • Suite 200 • Florham Park, NJ • 07932
Direct Dial: 973-622-8394 | Download VCard
jhalpern@saiber.com

Jakob B. Halpern counsels clients regarding intellectual property rights and represents them in intellectual property, employment, and other complex commercial litigation, with an emphasis on matters before the federal courts. His clients range from well-known consumer brands and pharmaceutical companies to local businesses and individuals.

Professional History

Prior to joining Saiber, Jake clerked for the Hon. William Matthew Byrne, Jr., on the United States District Court for the Central District of California, following a year as a litigation associate at a prominent D.C. law firm. He has also served as producer on a successful cable television news program.

Representative Matters

Negotiated several consent judgments for BMW and Rolls-Royce against infringers of their marks.

Represented a leather goods manufacturer in an unfair competition dispute against an unauthorized distributor.

Defended a beverage distributor against charges of trademark infringement by an energy drink manufacturer.

Represented a manufacturer of medical contrast dyes in a false advertising trial against a leading competitor.

Defended various generic drug manufacturers and cellular telephone providers in patent infringement lawsuits.

Successfully moved to dismiss an antitrust lawsuit against Pathmark Stores.

Represented Quest Diagnostics and its subsidiary in a lawsuit by the former CEO of the subsidiary for various contractual breaches.

Successfully moved to dismiss a breach of contract action by a former retailer for DIRECTV.

Secured a summary judgment concerning construction of intentional and criminals acts exclusions in a liability policy for a national insurer.

Noteworthy Decisions

Bracco Diagnostics, Inc. v. Amersham Health, Inc., 627 F. Supp. 2d 384 (D.N.J. 2009)

Allstate Ins. Co. v. Woods, 2008 WL 961240 (D.N.J. 2008)

Jacob Gunvalson, et al. v. PTC Therapeutics, Inc., Civil Action No. 08-3559 (WJM) (MF) (D.N.J. Aug. 21, 2008) Earned a preliminary injunction against a biotechnology company to enforce its promises to provide an investigational drug to a terminally ill teenager.